2014
DOI: 10.1038/srep04918
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Follow-up of Therapeutic ERCP in 78 Patients Aged 90 Years or Older

Abstract: This study aimed to determine the performance and long-term outcomes of therapeutic ERCP in very old patients. Patients aged or over 90 (Group A, n = 78) and consecutive sex-matched controls (Group B, n = 312) under 65 selected were compared. More patients in Group A had chronic concomitant diseases, but the success and complication rates were comparable. The follow-up of 61 patients (78.2%) in Group A were done, with a mean period of 27.5 (3–54) months. Seven patients survived; the main causes of death for th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
13
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 23 publications
7
13
0
Order By: Relevance
“…Table 2 highlights the findings of identified studies evaluating the safety of ERCP in nonagenarian patients. Of the identified studies 5 had control groups [ 10 , 12 , 13 , 16 , 17 ]. These studies also failed to show any significant difference in the procedural success or composite adverse event rates in nonagenarian patients.…”
Section: Discussionmentioning
confidence: 99%
“…Table 2 highlights the findings of identified studies evaluating the safety of ERCP in nonagenarian patients. Of the identified studies 5 had control groups [ 10 , 12 , 13 , 16 , 17 ]. These studies also failed to show any significant difference in the procedural success or composite adverse event rates in nonagenarian patients.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, China is a region with a high prevalence of pancreaticobiliary diseases. [20][21][22][23][24] The ERCP rates of developed countries may not be the benchmark for China in the recent period, but the significant shortage in lessdeveloped and remote regions instigated our concern in this area. The most developed region in China, Shanghai, had an ERCP rate of 99.1 per 100,000 inhabitants, which was comparable with that in developed countries.…”
Section: Discussionmentioning
confidence: 99%
“…While most studies to date have focused on the short-term complications of ERCP in the elderly, there is relatively little published data examining long-term outcomes in these patients. What data we do have suggest that complete treatment of biliary lithiasis may affect the overall survival of the elderly who require ERCP 14 . While the authors of Kenamori et al acknowledge that the broad time course of their study may have introduced unintended bias, it also permitted extended follow-up (a mean of 1278 days in the older cohort) in a fairly large number of patients.…”
mentioning
confidence: 86%